Medilink News Yorkshire & Humber - Autumn 2014 Autumn 2014 | Page 4

MEDILINK PRoFiT ™ INNOVATION AND PRODUCT DEVELOPMENT PROCESS Independent research has shown that companies are notoriously poor at identifying and progressing new product opportunities, with 90% of product launches ending in failure. In response to sector feedback, the programme calls on Medilink’s broad experience and expertise in the innovation space to help healthcare organisations grow and achieve their goals more quickly and effectively. The single most important differentiator between winners and losers, is the quality of the innovation process and techniques used to identify customer needs, identify the right types of technology and to develop and select optimum concepts. The diagram opposite shows Medilink’s PRoFiT™ Innovation and Product Development Process, highlighting the multiple factors that influence taking a product from concept through to launch. The benefits of this process include significantly higher sales, profits and turnover, a reduction in the cost and time of product development and the avoidance of failed projects. In addition, Medilink offers project management and ‘hands on’ support for the development of new products and services (see below and diagram opposite). This new service is being delivered by Medilink’s Innovation experts Dr Patrick Trotter and Dr Paul Watt, who have over 40 years experience of working in research and business development within global medical device, bio devices and life sciences. The PRoFit Innovation and Product Development Process utilises multiple processes for helping companies identify new product ideas. We can apply these to all your innovation and new product development projects to reduce risk and enhance commercial return. Due diligence - early stage technologies According to the British Venture Capital Association, only 10% of all investments are successful. Medilink provides early stage market opportunity and technology feasibility assessments to aid potential investment opportunities and reduce technical and commercial risks. Technology strategy development Our experts will sit down with key members of your company and scope out where you want to go as a company in terms of new products and help formulate a plan of action using portfolio analysis and other tools, to get you there. Technology mapping Customer needs A process to identify gaps in technology areas. The outputs include: In addition to traditional market research, there are techniques now recognised as providing better outcomes for ensuring you deliver the right product into the right market. Techniques such as ‘Lead user’ and particularly ‘Ethnography’, help you to understand what the customer really wants. • Generation of ideas • Identify technologies in your strategic space • Highlight intellectual property (IP) that needs to be licensed or generated • Identify competitor technologies • Highlight technology trends Clinical evidence reports Competitor landscaping An evaluation of all clinical data is required for all CE marked products sold in Europe. This technique is an excellent tool to look at your product landscape and what the competitors are doing in terms of: • What they have in development • Who they are partnering with such as academics, clinicians and other companies • What IP they are generating or acquiring • What clinical studies they are conducting • What products they have, and who they have recently acquired 04 In addition to meeting legal requirements, clinical evaluation reports can help you identify opportunities to increase the number of product claims and therefore providing competitive advantage. Medilink can help produce preliminary short clinical evaluations or more detailed evaluations. We have extensive experience in writing evidence reports as outlined in the European Commission Guidelines on Medical Devices MEDDEV 2.7.1. REV 3.